{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:07:07Z","timestamp":1788264427071,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":397,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1124\/dmd.123.001402","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T20:35:16Z","timestamp":1695069316000},"page":"1569-1577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase\/Reductase Isoforms in the Human Intestine"],"prefix":"10.1016","volume":"51","author":[{"given":"Keiya","family":"Hirosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hijiri","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-8178","authenticated-orcid":false,"given":"Hiroyuki","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.123.001402_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.dmpk.2020.08.004","article-title":"Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase\/reductase isoforms in human livers","volume":"35","author":"Amai","year":"2020","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.123.001402_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/03602530802431439","article-title":"The aldo-keto reductase superfamily and its role in drug metabolism and detoxification","volume":"40","author":"Barski","year":"2008","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.123.001402_bib3","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1211\/0022357045020","article-title":"Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol","volume":"56","author":"Breyer-Pfaff","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.123.001402_bib4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/dmd.116.070763","article-title":"Prevalence of non-cytochrome P450-mediated metabolism in food and drug administration-approved oral and intravenous drugs: 2006-2015","volume":"44","author":"Cerny","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001402_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1124\/dmd.123.001402_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat Methods"},{"key":"10.1124\/dmd.123.001402_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-pharmtox-052220-105907","article-title":"Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and Development","volume":"62","author":"Fukami","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.123.001402_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/tx010005p","article-title":"Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases","volume":"14","author":"Guengerich","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.123.001402_bib10","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1023\/A:1016217822770","article-title":"The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit","volume":"12","author":"Homsy","year":"1995","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.123.001402_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4939-9164-8_5","article-title":"A standardized and reproducible proteomics protocol for bottom-up quantitative analysis of protein samples using SP3 and mass spectrometry","volume":"1959","author":"Hughes","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.123.001402_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/dmd.122.001037","article-title":"Quantitative evaluation of the contribution of each aldo-keto reductase and short-chain dehydrogenase\/reductase isoform to reduction reactions of compounds containing a ketone group in the human liver","volume":"51","author":"Ichida","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001402_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109536","article-title":"Identification of HSD17B12 as an enzyme catalyzing drug reduction reactions through investigation of nabumetone metabolism","volume":"736","author":"Ichida","year":"2023","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.123.001402_bib14","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1124\/dmd.108.022251","article-title":"Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver","volume":"36","author":"Kassner","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001402_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-94-024-0945-1_5","article-title":"Retinoic acid synthesis and degradation","volume":"81","author":"Kedishvili","year":"2016","journal-title":"Subcell Biochem"},{"key":"10.1124\/dmd.123.001402_bib16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12253-014-9751-4","article-title":"Altered expression of multiple genes involved in retinoic acid biosynthesis in human colorectal cancer","volume":"20","author":"Kropotova","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"10.1124\/dmd.123.001402_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003088-199937060-00001","article-title":"Pharmacokinetics of haloperidol: an update","volume":"37","author":"Kudo","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.123.001402_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1124\/dmd.104.002006","article-title":"Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)","volume":"33","author":"Lakhman","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001402_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cbi.2014.07.005","article-title":"The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man","volume":"220","author":"Mal\u00e1tkov\u00e1","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.123.001402_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/03602532.2013.853078","article-title":"Carbonyl reduction pathways in drug metabolism","volume":"46","author":"Mal\u00e1tkov\u00e1","year":"2014","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.123.001402_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1124\/dmd.105.007971","article-title":"Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics","volume":"34","author":"Martin","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001402_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2133\/dmpk.21.1","article-title":"Multiplicity of mammalian reductases for xenobiotic carbonyl compounds","volume":"21","author":"Matsunaga","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.123.001402_bib23","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1124\/dmd.113.052936","article-title":"Formation of threohydrobupropion from bupropion is dependent on 11\u03b2-hydroxysteroid dehydrogenase 1","volume":"41","author":"Meyer","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001402_bib24","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1021\/acs.molpharmaceut.2c01002","article-title":"Regional transcriptomics and proteomics of pharmacokinetics-related genes in human intestine","volume":"20","author":"Murata","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.123.001402_bib25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1124\/dmd.113.051177","article-title":"Significance of reductive metabolism in human intestine and quantitative prediction of intestinal first-pass metabolism by cytosolic reductive enzymes","volume":"41","author":"Nishimuta","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001402_bib26","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1158\/1541-7786.MCR-13-0330-T","article-title":"AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis","volume":"11","author":"Ohashi","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1124\/dmd.123.001402_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-2952(95)00124-I","article-title":"Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver","volume":"50","author":"Ohara","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.123.001402_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/138920008783571774","article-title":"Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues","volume":"9","author":"Pavek","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.123.001402_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cbi.2014.09.024","article-title":"The aldo-keto reductases (AKRs): Overview","volume":"234","author":"Penning","year":"2015","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.123.001402_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/er.2018-00089","article-title":"Structural and functional biology of aldo-keto reductase steroid-transforming enzymes","volume":"40","author":"Penning","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1124\/dmd.123.001402_bib32","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biol"},{"key":"10.1124\/dmd.123.001402_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fphar.2012.00058","article-title":"Biological role of aldo-keto reductases in retinoic Acid biosynthesis and signaling","volume":"3","author":"Ruiz","year":"2012","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.123.001402_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbi.2014.11.010","article-title":"Metabolism of doxorubicin to the cardiotoxic metabolite doxorubicinol is increased in a mouse model of chronic glutathione deficiency: A potential role for carbonyl reductase 3","volume":"234","author":"Schaupp","year":"2015","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.123.001402_bib35","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1158\/1078-0432.CCR-14-2072","article-title":"Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice","volume":"21","author":"Shen","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.123.001402_bib36","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1021\/acs.jproteome.7b00433","article-title":"Evaluation of FASP, SP3, and iST Protocols for Proteomic Sample Preparation in the Low Microgram Range","volume":"16","author":"Sielaff","year":"2017","journal-title":"J Proteome Res"},{"key":"10.1124\/dmd.123.001402_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/03602532.2011.638304","article-title":"Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily","volume":"44","author":"Skarydov\u00e1","year":"2012","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.123.001402_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0090-6980(02)00050-3","article-title":"Prostaglandin catabolizing enzymes","volume":"68-69","author":"Tai","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1124\/dmd.123.001402_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1124\/dmd.120.000283","article-title":"In vivo gene expression profile of human intestinal epithelial cells: From the viewpoint of drug metabolism and pharmacokinetics","volume":"49","author":"Takayama","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001402_bib40","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1124\/dmd.106.013565","article-title":"Molecular mechanism of basal CYP3A4 regulation by hepatocyte nuclear factor 4\u03b1: evidence for direct regulation in the intestine","volume":"35","author":"Tegude","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001402_bib41","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s11095-007-9519-6","article-title":"Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms","volume":"25","author":"Tubic-Grozdanis","year":"2008","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.123.001402_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12064-012-0162-3","article-title":"Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples","volume":"131","author":"Wagner","year":"2012","journal-title":"Theory Biosci"},{"key":"10.1124\/dmd.123.001402_bib43","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.12688\/f1000research.15931.1","article-title":"FastQ Screen: A tool for multi-genome mapping and quality control","volume":"7","author":"Wingett","year":"2018","journal-title":"F1000 Res"},{"key":"10.1124\/dmd.123.001402_bib44","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1177\/40.12.1453004","article-title":"Immunohistochemical localization of carbonyl reductase in human tissues","volume":"40","author":"Wirth","year":"1992","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/dmd.123.001402_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tox.2007.05.021","article-title":"Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man","volume":"238","author":"Wsol","year":"2007","journal-title":"Toxicology"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624010948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624010948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.123.001402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:06:19Z","timestamp":1739955979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624010948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0090955624010948"],"URL":"https:\/\/doi.org\/10.1124\/dmd.123.001402","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase\/Reductase Isoforms in the Human Intestine","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.123.001402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The Author(s)","name":"copyright","label":"Copyright"}]}}